We are live on ! Find out more
CTC

Central Trust Company Portfolio holdings

AUM $5.53B
1-Year Est. Return 28.91%
This Fund
S&P 500
This Quarter Est. Return
-10.33%
1 Year Est. Return
+28.91%
3 Year Est. Return
+83.91%
5 Year Est. Return
+104.79%
10 Year Est. Return
+351.32%
AUM
$1.5B
AUM Growth
-$216M
Cap. Flow
-$12.7M
Cap. Flow %
-0.85%
Top 10 Hldgs %
22.86%
Holding
1,332
New
56
Increased
233
Reduced
440
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Healthcare 12.63%
3 Industrials 10.84%
4 Consumer Staples 10.04%
5 Financials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COL
1251
DELISTED
Rockwell Collins
COL
-683
Closed -$96K
PX
1252
DELISTED
Praxair Inc
PX
-7,913
Closed -$1.27M
PF
1253
DELISTED
Pinnacle Foods, Inc.
PF
-4,683
Closed -$304K
EVHC
1254
DELISTED
Envision Healthcare Holdings Inc
EVHC
-3,467
Closed -$159K
GPT
1255
DELISTED
Gramercy Property Trust
GPT
-186
Closed -$5K
ANDV
1256
DELISTED
Andeavor
ANDV
-9,350
Closed -$1.44M
BTX.WS
1257
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
-4
Closed
GST
1258
DELISTED
Gastar Exploration Inc.
GST
$0 ﹤0.01%
11,335
OIBR
1259
DELISTED
OI S A SPONSORED ADR REPSTG PFD NEW (BRA)
OIBR
$0 ﹤0.01%
150
IFX
1260
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
-52
Closed -$1K
CA
1261
DELISTED
CA, Inc.
CA
-4,693
Closed -$207K
SBNY
1262
DELISTED
Signature Bank
SBNY
-47
Closed -$5K
JTA
1263
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
-800
Closed -$11K
CEO
1264
DELISTED
CNOOC Limited
CEO
-342
Closed -$68K
FTR
1265
DELISTED
Frontier Communications Corp.
FTR
-2
Closed
AST
1266
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$0 ﹤0.01%
41
INP
1267
DELISTED
iPath ETNs Linked to the MSCI India Total Return Index
INP
-150
Closed -$12K
GCVRZ
1268
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
1,534
AV
1269
DELISTED
Aviva Plc
AV
-750
Closed -$10K

Similar funds

Central Trust Company's Q4 2018 Portfolio in Review

As of Q4 2018, Central Trust Company held 1,332 positions worth $1.5B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Central Trust Company's Q4 2018 filing shows 56 new, 233 increased, 440 reduced and 129 closed positions. Its largest new stake was Linde: 11,110 shares worth $1.73M. The largest sale was Express Scripts Holding Company, an estimated $6.69M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

  • Central Trust Company's largest Q4 2018 buy was Linde: 11,110 shares worth $1.73M.
  • Central Trust Company added most to Schwab US Dividend Equity ETF in Q4 2018, an estimated $6.35M increase.
  • Central Trust Company's biggest Q4 2018 reduction was iShares Gold Trust, cutting an estimated $4.22M.
  • Central Trust Company fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $6.69M.
  • Central Trust Company's ten largest holdings make up 23% of its $1.5B portfolio in Q4 2018.
  • Central Trust Company opened 56 new positions and closed 129 in Q4 2018.
  • Central Trust Company's portfolio value fell 13% quarter-over-quarter to $1.5B.

Based on Central Trust Company's 13F filing for Q4 2018, filed 8 Jan 2019.